Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).\nNimptsch K, Rohrmann S, Linseisen J.\nAm J Clin Nutr. 2008 Apr;87(4):985-92.\nPMID: 18400723
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J. \nn-3 Fatty acids from fish or fish-oil supplements, but not \nalpha-linolenic acid, benefit cardiovascular disease outcomes in \nprimary- and secondary-prevention studies: a systematic review. \nAm J Clin Nutr. 2006 Jul;84(1):5-17. Review. \nPMID: 16825676
Heaney RP.
Long-latency deficiency disease: insights from calcium and vitamin D.
Am J Clin Nutr. 2003 Nov;78(5):912-9. Review.
PMID: 14594776 [PubMed - indexed for MEDLINE]
Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study.
Gebauer SK, West SG, Kay CD, Alaupovic P, Bagshaw D, Kris-Etherton PM.
Am J Clin Nutr. 2008 Sep;88(3):651-9.
PMID: 18779280
Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes.
Ros E.
Am J Clin Nutr. 2003 Sep;78(3 Suppl):617S-625S. Review.
PMID: 12936956
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP.
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.
Am J Clin Nutr. 2007 Jun;85(6):1586-91.
PMID: 17556697 [PubMed - indexed for MEDLINE]
Safety of vitamin D3 in adults with multiple sclerosis.
Kimball SM, Ursell MR, O'Connor P, Vieth R.
Am J Clin Nutr. 2007 Sep;86(3):645-51.
PMID: 17823429
Conclusions: Patients' serum 25(OH)D concentrations reached twice the top of the physiologic range without eliciting hypercalcemia or hypercalciuria. The data support the feasibility of pharmacologic doses of vitamin D3 for clinical research, and they provide objective evidence that vitamin D intake beyond the current upper limit is safe by a large margin.